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Abstract
Purpose. Transmission of malignant tumour cells to a bone graft donor site is a rare complication of bone grafting. We
report a case of seeding of malignant ® brous histiocytoma from the femur to a pelvic bone graft donor site.
Discussion. We review the literature, discuss the possible mechanism of tumour transfer and offer advice aimed at avoiding
this complication.
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Introduction
Autologousbonegraftingremainsa commonmethod
of reconstructing bone defects following the surgical
treatment of primary bone tumours. Complications
from this procedure are not uncommon.
1
Transplantation of tumour cells from the primary
site of tumour to the graft donor site is rare but has
been reported in differenttissues such as the skin and
bones.
2± 6 However, the exact mechanism of seeding
of the primary tumour to graft donor site is unclear
and controversial.It is possible that seedingis a result
of poor surgical technique allowing direct transfer of
tumours from the primary site to the donor site or it
may result from haematogenous transfer.
We report a case of seeding of malignant ® brous
histiocytoma from the femur to the iliac crest bone
graft donor site, review the literature of this
unfortunate complication and discuss the possible
mechanismof seedingtumour cells to the graft donor
site.We offer advice on how to avoid this complica-
tion.
Case report
A 49-year-old man presented to his local hospital
with a 3-month history of pain in the left thigh.There
was no swelling and haematological tests were normal.
Plain X-rays revealed a lytic lesion of the left distal
femur (Fig. 1). A trephine biopsy of the lesion was
performed by the local surgeon and was reported as
showing no evidence of malignancy, but no de® nite
diagnosis was made.
The lesion was curetted and the defect in the distal
femur packed with autologous left iliac crest bone
graft supplemented by blocks of bank allograft. A
condylar blade plate was applied over the grafted
femur.No operative notes were made in the patient’s
records to determine whether the graft was obtained
before the tumour was curetted or if the surgical
instruments had been changed.
Histology of the curettings,however,showed a high
grade malignant ® brous histiocytoma. The patient
was referred to a specialist orthopaedic centre 3
months after the initial presentation and the
histologicaldiagnosiswas con® rmed.Comprehensive
tumour staging studies including serum haemato-
logical and biological tests, computed tomography
(CT) scan of the chest and whole body bone scintig-
raphy revealed no metastases.The patient was treated
with chemotherapy, surgical resection and endopros-
thetic replacement of 85% of the distal femur.
Eighteen months after the initial curettage and
donor bonegraft the patient developed a painful lump
under the iliac crest scar at the site of the previous
bone graft. Magnetic resonance imaging (MRI) scan
and biopsy of this lesion (Fig. 2) showed a high grade
malignant ® brous histiocytoma. Further staging
studies revealed no other metastasis. Excision of the
tumour in continuity with the involved iliac crest was
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years, but subsequently developed metastases that
led to his death 6 years from the time of initial
presentation.
Discussion
Accurate pathological diagnosis of musculoskeletal
tumours is a prerequisite for optimal management of
malignant bone and soft tissue tumours. Errors in
diagnosis of the biopsy specimen may occur in up to
25% of patients with possible implications on the
treatmentrecommendedwhen biopsyand histological
examination are performedat non-oncologycentres.
7
Hence, the recommendation that biopsy of suspi-
cious bone and soft tissue lesions and interpretation
of histology should be performed at specialist
orthopaedic oncologycentres with experiencein bone
and soft tissue sarcoma.This is clearly illustrated by
the case presented.
Inadvertentcontaminationof a wound with tumour
cells leads to a risk of local recurrence but the exact
incidence of this is unknown. The presence of free
tumourcells on surgical instrumentsand glovesraises
the theoretical possibility of direct transplantation of
tumour by this route.
8± 10 This may represent the
mode of metastasis of malignant cells to bone graft
donor site when a de® nitive operation and autolo-
gous bone grafting are performed at the same sitting
without usingdifferentinstrumentsor glovesto obtain
the graft.
Experimental evidence exists that trauma may
predisposeto localization of malignantcellsin injured
tissues.The exact mechanism of this is unclear and
may, at least in part, be due to adherence of tumour
cellsto damaged endotheliumof the micro-circulation
at such areas or alteration of blood ¯ ow or coagula-
tion mechanism in the traumatized areas.
11± 13Yip et
al.
6reporteda case of pelvic osteosarcomawith metas-
tases to the ® bular donor site 6 years after the initial
excision of the pelvic osteosarcoma with pelvic
reconstruction using a ® bular strut graft at an
orthopaedic oncology centre. The ® bular graft had
been harvested, graft donor site wound closed and
instruments changed prior to excision of the pelvic
tumour.This case supports the possibility of haema-
togenous seeding of tumour cells to a surgically
traumatized bone graft donor site.
Autologous bone graft donor sites create a suitable
tissue surface for eventual transplantation of
malignant cells, if bone grafting is performed at the
same time as the de® nitive tumour operation. The
Fig.1. Plain radiographs of the lesion in the femur (IA antero-posterior view;IB lateral view).
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overemphasized and where possible the surgeon
should avoid autologous graft if alternative means of
reconstruction of defeats are available.
There may be situations where autologous bone
grafts cannot be avoided. In these situations,
meticulous operative technique to minimize seeding
tumoursis mandatory.Theseincludechangingdrapes,
instruments and gloves when autologous bone graft
is harvested following tumour removal, whatever the
biopsy report. In our institution we keep the donor
site covered with sterile drapes until that part of the
case is performed.We change gloves, all instruments,
diathermy, suction tips and light handles before bone
graft is harvested, where potential seeding of tumour
cells could occur.Where possible, the tumour should
be excised® rst and then the graftharvested to prevent
a `congenial soil’
14 being present at the time that
potential tumour cells are in the circulation. It is
important to document this in the operation record
to avoid any future medico-legal implications.
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Fig. 2. MRI scan of the pelvis with arrow pointing to the seeded tumour in the iliac wing.
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